Tanager Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Buy
4,146
+207
+5% +$44.5K 0.09% 56
2026
Q1
$857K Buy
3,939
+71
+2% +$15.7K 0.08% 61
2025
Q4
$884K Sell
3,868
-59
-2% -$13.4K 0.09% 59
2025
Q3
$909K Sell
3,927
-411
-9% -$83.7K 0.1% 59
2025
Q2
$805K Buy
4,338
+273
+7% +$50.7K 0.1% 58
2025
Q1
$852K Buy
4,065
+558
+16% +$108K 0.11% 51
2024
Q4
$623K Buy
3,507
+596
+20% +$110K 0.08% 57
2024
Q3
$575K Sell
2,911
-18
-0.6% -$3.36K 0.08% 59
2024
Q2
$502K Hold
2,929
0.07% 58
2024
Q1
$533K Buy
2,929
+646
+28% +$111K 0.09% 54
2023
Q4
$354K Sell
2,283
-378
-14% -$55.1K 0.06% 63
2023
Q3
$397K Buy
2,661
+40
+2% +$5.87K 0.08% 54
2023
Q2
$353K Buy
2,621
+102
+4% +$15K 0.08% 61
2023
Q1
$401K Buy
2,519
+245
+11% +$37.5K 0.1% 52
2022
Q4
$368K Buy
2,274
+274
+14% +$42K 0.1% 52
2022
Q3
$268K Hold
2,000
0.21% 34
2022
Q2
$306K Hold
2,000
0.25% 30
2022
Q1
$324K Hold
2,000
0.24% 30
2021
Q4
$271K Buy
+2,000
New +$236K 0.2% 34

Other funds holding ABBV

Tanager Wealth Management's ABBV Position: Q2 2026 in Review

Tanager Wealth Management increased its AbbVie (ABBV) stake by 5.3% in Q2 2026, buying an estimated $44.5K and bringing the position to 4,146 shares worth $1.04M. The position accounts for 0.09% of the portfolio, ranked #56.

Tanager Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Tanager Wealth Management held 4,146 shares of AbbVie worth $1.04M as of Q2 2026.
  • Tanager Wealth Management bought 207 AbbVie shares in Q2 2026, an estimated $44.5K.
  • AbbVie made up 0.09% of Tanager Wealth Management's portfolio in Q2 2026, its #56 holding.
  • Tanager Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tanager Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.